Autophagy

T-271 is a selective inducer of mitochondrial autophagy, specifically targeting the regulation of mitophagy processes within cells. This compound facilitates the degradation and removal of damaged mitochondria, promoting cellular homeostasis and contributing to mitochondrial quality control. T-271 is primarily utilized in research focused on metabolic disorders, neurodegeneration, and other conditions associated with mitochondrial dysfunction.

Cys-C-cGMP is an autophagy tag designed for AUTACs that facilitates the selective degradation of target proteins through autophagy. It enhances K63-linked ubiquitination of mitochondria in HeLa cells, thereby promoting cellular quality control and elimination of damaged organelles. This compound is valuable for studying autophagy-related pathways and the development of targeted protein degradation strategies.

Clinopodiside A is a triterpenoid saponin that acts as an autophagy inducer. Isolated from the traditional Chinese medicinal herb Clinopodium polycephalum, it demonstrates significant potential in modulating cellular autophagy processes. This compound is useful for research applications exploring autophagy-related pathways and their implications in various diseases.

Corynoxine B is an alkaloid that acts as an autophagy inducer and an inhibitor of α-synuclein aggregation. It has demonstrated the ability to mitigate manganese-induced dysregulation of autophagy, thereby enhancing the clearance of α-synuclein in models of Parkinson's disease. This compound serves as a valuable tool for research into neurodegenerative disorders and the underlying mechanisms of autophagy regulation.

Xylitol is a polyol classified as a sugar alcohol, known for its inhibitory effects on cancer cell proliferation. It induces autophagy and promotes cell death in A549 lung cancer cells by activating the autophagy signaling pathway, as indicated by increased levels of LC3-II and Atg5-Atg12. Additionally, Xylitol reduces acetaldehyde production by Candida species, thereby mitigating their carcinogenic potential. In vivo studies demonstrate that Xylitol modifies gut microbiota in mice, potentially enhancing cholesterol accumulation, upregulating hepatic ChREBP, and inhibiting tumor growth in the B16F10 melanoma model.